Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

418

HTML

2802

Figures (1-2)

227

Tables (1-3)

187

Sum=3634

May 21, 2012 (publication date) through Dec 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 21, 2012; 18(19): 2423-2429
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2423

Table 3 Survival estimates and 95% confidence intervals for disease-related deaths

Groups	Median survival (mo)	1-yr survival rate (%)	3-yr survival rate (%)	χ²	Pvalue
Low Popdc3 expression	23 (21.20-24.79)	175 (76.75)	38 (16.7)
High Popdc3 expression	55 (53.51-56.48)	69 (88.46)	66 (84.6)	145.095	< 0.0001
Stage I-II with low Popdc3 expression	29 (21.00-38.00)	97 (87.39)	44 (39.64)
Stage I-II with high Popdc3 expression	55 (45.00-61.00)	65 (91.55)	65 (91.55)	104.741	< 0.0001
Stage III-IV with low Popdc3 expression	15 (10.00-21.50)	78 (66.67)	12 (10.26)
Stage III-IV with high Popdc3 expression	30 (12.00-44.00)	4 (57.14)	3 (42.86)	5.93	0.015

Popdc3: Popeye domain containing 3.

Citation: Luo D, Lu ML, Zhao GF, Huang H, Zheng MY, Chang J, Lv L, Luo JB. Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer. World J Gastroenterol 2012; 18(19): 2423-2429
URL: https://www.wjgnet.com/1007-9327/full/v18/i19/2423.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i19.2423